 Douglas Taren
Concepts (351)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin A Deficiency | 6 | 2019 | 27 | 1.640 |
Why?
| | Diet | 10 | 2023 | 1075 | 1.550 |
Why?
| | Agricultural Irrigation | 2 | 2019 | 2 | 1.230 |
Why?
| | Ecosystem | 2 | 2023 | 527 | 1.220 |
Why?
| | Anemia, Iron-Deficiency | 3 | 2019 | 54 | 1.210 |
Why?
| | Solar Energy | 2 | 2019 | 32 | 1.190 |
Why?
| | Food Supply | 4 | 2023 | 62 | 0.970 |
Why?
| | Acanthosis Nigricans | 1 | 2023 | 6 | 0.900 |
Why?
| | Pregnancy in Adolescence | 1 | 2023 | 80 | 0.830 |
Why?
| | Education, Public Health Professional | 2 | 2015 | 6 | 0.830 |
Why?
| | Nutritional Sciences | 2 | 2021 | 35 | 0.820 |
Why?
| | Resilience, Psychological | 1 | 2023 | 99 | 0.820 |
Why?
| | Nutritional Status | 9 | 2023 | 287 | 0.790 |
Why?
| | Anthropometry | 4 | 2018 | 182 | 0.770 |
Why?
| | Climate Change | 1 | 2022 | 127 | 0.720 |
Why?
| | Premature Birth | 1 | 2023 | 278 | 0.690 |
Why?
| | Diabetes, Gestational | 1 | 2023 | 274 | 0.660 |
Why?
| | Iron | 2 | 2019 | 235 | 0.650 |
Why?
| | Vitamin A | 7 | 2019 | 52 | 0.650 |
Why?
| | Rural Population | 6 | 2017 | 449 | 0.650 |
Why?
| | Thinness | 1 | 2019 | 87 | 0.650 |
Why?
| | Lasers | 1 | 2018 | 123 | 0.590 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2023 | 2091 | 0.570 |
Why?
| | Poverty | 2 | 2017 | 444 | 0.540 |
Why?
| | Crops, Agricultural | 1 | 2016 | 31 | 0.530 |
Why?
| | Problem-Based Learning | 1 | 2015 | 77 | 0.470 |
Why?
| | Public Health | 2 | 2018 | 439 | 0.470 |
Why?
| | Benin | 3 | 2019 | 5 | 0.450 |
Why?
| | Energy Intake | 4 | 2023 | 413 | 0.440 |
Why?
| | Program Evaluation | 3 | 2016 | 839 | 0.430 |
Why?
| | Microbiota | 1 | 2017 | 651 | 0.360 |
Why?
| | Healthcare Disparities | 1 | 2015 | 486 | 0.340 |
Why?
| | Maternal-Child Health Centers | 1 | 2008 | 9 | 0.330 |
Why?
| | Humans | 52 | 2023 | 115908 | 0.320 |
Why?
| | Socioeconomic Factors | 6 | 2019 | 1090 | 0.310 |
Why?
| | Nutritional Physiological Phenomena | 3 | 2021 | 48 | 0.300 |
Why?
| | Night Blindness | 2 | 2004 | 6 | 0.290 |
Why?
| | Female | 37 | 2023 | 60086 | 0.290 |
Why?
| | Electric Countershock | 9 | 1980 | 101 | 0.290 |
Why?
| | Universities | 1 | 2008 | 341 | 0.270 |
Why?
| | Breast Feeding | 2 | 2023 | 371 | 0.270 |
Why?
| | Cooperative Behavior | 1 | 2008 | 390 | 0.270 |
Why?
| | Gardening | 2 | 2019 | 9 | 0.270 |
Why?
| | Prenatal Care | 2 | 2023 | 257 | 0.270 |
Why?
| | Child, Preschool | 13 | 2023 | 9175 | 0.260 |
Why?
| | Body Mass Index | 6 | 2023 | 1982 | 0.260 |
Why?
| | Body Image | 3 | 2008 | 75 | 0.250 |
Why?
| | Surveys and Questionnaires | 7 | 2020 | 4670 | 0.250 |
Why?
| | Kenya | 3 | 2022 | 98 | 0.240 |
Why?
| | Education, Distance | 2 | 2019 | 36 | 0.240 |
Why?
| | Adolescent | 10 | 2023 | 17955 | 0.230 |
Why?
| | Infectious Disease Transmission, Vertical | 2 | 2022 | 152 | 0.230 |
Why?
| | Pregnancy Complications | 2 | 2005 | 431 | 0.220 |
Why?
| | Starch | 1 | 2023 | 21 | 0.220 |
Why?
| | Sugars | 1 | 2023 | 29 | 0.220 |
Why?
| | Adult | 18 | 2023 | 30820 | 0.220 |
Why?
| | Agriculture | 1 | 2023 | 76 | 0.220 |
Why?
| | Eating | 4 | 2011 | 350 | 0.210 |
Why?
| | Infant | 9 | 2023 | 8002 | 0.210 |
Why?
| | Young Adult | 5 | 2019 | 10518 | 0.210 |
Why?
| | Food Services | 3 | 1991 | 19 | 0.210 |
Why?
| | Dietary Carbohydrates | 1 | 2023 | 136 | 0.210 |
Why?
| | Pregnancy | 8 | 2023 | 5556 | 0.200 |
Why?
| | Vegetables | 2 | 2022 | 129 | 0.200 |
Why?
| | Feeding Behavior | 5 | 2023 | 573 | 0.200 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2023 | 133 | 0.200 |
Why?
| | Knowledge | 1 | 2022 | 52 | 0.200 |
Why?
| | Food Assistance | 1 | 2022 | 21 | 0.200 |
Why?
| | Self-Management | 1 | 2023 | 126 | 0.190 |
Why?
| | Social Desirability | 2 | 2006 | 14 | 0.190 |
Why?
| | Early Diagnosis | 1 | 2022 | 221 | 0.190 |
Why?
| | HIV | 1 | 2022 | 209 | 0.180 |
Why?
| | Infant, Low Birth Weight | 2 | 1991 | 125 | 0.180 |
Why?
| | Nutrition Disorders | 3 | 2011 | 23 | 0.180 |
Why?
| | Mothers | 3 | 2022 | 667 | 0.180 |
Why?
| | Birth Weight | 1 | 2023 | 439 | 0.180 |
Why?
| | Diet Records | 6 | 2006 | 76 | 0.180 |
Why?
| | Cacao | 1 | 1999 | 6 | 0.170 |
Why?
| | Child | 8 | 2023 | 18555 | 0.170 |
Why?
| | Integrative Medicine | 1 | 2019 | 5 | 0.170 |
Why?
| | Psychopharmacology | 1 | 1999 | 7 | 0.170 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2000 | 86 | 0.170 |
Why?
| | Curriculum | 3 | 2020 | 853 | 0.170 |
Why?
| | Male | 22 | 2022 | 56128 | 0.160 |
Why?
| | Contraception Behavior | 1 | 2019 | 80 | 0.160 |
Why?
| | Contraceptive Agents | 1 | 2019 | 55 | 0.160 |
Why?
| | Infant, Newborn | 5 | 2023 | 5089 | 0.160 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2000 | 125 | 0.160 |
Why?
| | Behavior, Addictive | 1 | 1999 | 78 | 0.160 |
Why?
| | Nutrition Surveys | 2 | 2017 | 225 | 0.160 |
Why?
| | Nutrition Assessment | 2 | 2017 | 76 | 0.160 |
Why?
| | Family Planning Services | 1 | 2019 | 67 | 0.160 |
Why?
| | Micronutrients | 1 | 2019 | 77 | 0.160 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2022 | 289 | 0.160 |
Why?
| | Dietary Fats | 1 | 2000 | 291 | 0.150 |
Why?
| | HIV Infections | 2 | 2022 | 2470 | 0.150 |
Why?
| | Feeding and Eating Disorders | 1 | 1999 | 120 | 0.150 |
Why?
| | Middle Aged | 10 | 2019 | 27084 | 0.150 |
Why?
| | Nigeria | 3 | 2022 | 14 | 0.150 |
Why?
| | Adaptation, Psychological | 1 | 2022 | 551 | 0.150 |
Why?
| | Orosomucoid | 1 | 2017 | 5 | 0.150 |
Why?
| | Observer Variation | 1 | 2018 | 299 | 0.140 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2017 | 19 | 0.140 |
Why?
| | Quality Indicators, Health Care | 1 | 2019 | 285 | 0.140 |
Why?
| | Cross-Sectional Studies | 7 | 2022 | 4449 | 0.140 |
Why?
| | Pilot Projects | 2 | 2019 | 1374 | 0.140 |
Why?
| | Ferritins | 1 | 2017 | 57 | 0.140 |
Why?
| | Self Disclosure | 2 | 2008 | 59 | 0.140 |
Why?
| | Retinal Detachment | 2 | 1995 | 53 | 0.140 |
Why?
| | Smoking Cessation | 2 | 2016 | 378 | 0.130 |
Why?
| | Arizona | 2 | 2015 | 67 | 0.130 |
Why?
| | Bupropion | 1 | 2016 | 39 | 0.130 |
Why?
| | Intestinal Diseases, Parasitic | 3 | 1992 | 11 | 0.130 |
Why?
| | Pregnancy Complications, Hematologic | 2 | 2012 | 16 | 0.130 |
Why?
| | Health Status Disparities | 1 | 2017 | 208 | 0.130 |
Why?
| | Schools, Public Health | 1 | 2015 | 3 | 0.130 |
Why?
| | Hospitals, Rural | 1 | 2015 | 31 | 0.130 |
Why?
| | Poverty Areas | 1 | 2015 | 33 | 0.130 |
Why?
| | Education, Graduate | 1 | 2015 | 32 | 0.120 |
Why?
| | Urban Health | 1 | 2015 | 75 | 0.120 |
Why?
| | Scleral Buckling | 2 | 1995 | 18 | 0.120 |
Why?
| | C-Reactive Protein | 1 | 2017 | 364 | 0.120 |
Why?
| | Reproducibility of Results | 4 | 2018 | 2814 | 0.120 |
Why?
| | Social Justice | 1 | 2015 | 66 | 0.120 |
Why?
| | Prevalence | 4 | 2017 | 2270 | 0.120 |
Why?
| | Logistic Models | 2 | 2017 | 1865 | 0.120 |
Why?
| | Stress, Physiological | 1 | 2017 | 397 | 0.120 |
Why?
| | Health Personnel | 1 | 2020 | 578 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2017 | 323 | 0.120 |
Why?
| | Ascariasis | 3 | 1988 | 3 | 0.120 |
Why?
| | Anemia | 2 | 2012 | 144 | 0.110 |
Why?
| | Growth | 1 | 1993 | 56 | 0.110 |
Why?
| | Tobacco Use Disorder | 1 | 2016 | 238 | 0.110 |
Why?
| | Primary Health Care | 2 | 2022 | 1517 | 0.110 |
Why?
| | Sodium Glutamate | 1 | 2012 | 7 | 0.110 |
Why?
| | Vision Tests | 2 | 2004 | 15 | 0.110 |
Why?
| | Depression | 2 | 2006 | 1149 | 0.110 |
Why?
| | Neurotoxins | 1 | 2012 | 26 | 0.110 |
Why?
| | Program Development | 1 | 2015 | 349 | 0.110 |
Why?
| | India | 2 | 2023 | 135 | 0.110 |
Why?
| | Irritable Bowel Syndrome | 1 | 2012 | 29 | 0.110 |
Why?
| | Indians, Central American | 1 | 1992 | 6 | 0.100 |
Why?
| | Delivery of Health Care | 1 | 2019 | 847 | 0.100 |
Why?
| | Nepal | 3 | 2012 | 20 | 0.100 |
Why?
| | Self Concept | 2 | 2008 | 218 | 0.100 |
Why?
| | Fibromyalgia | 1 | 2012 | 56 | 0.100 |
Why?
| | Risk Factors | 7 | 2017 | 8714 | 0.100 |
Why?
| | Chronic Disease | 1 | 2017 | 1602 | 0.100 |
Why?
| | Electrodes | 4 | 1979 | 99 | 0.100 |
Why?
| | Obstetric Labor, Premature | 1 | 1991 | 33 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 1193 | 0.100 |
Why?
| | Glutamic Acid | 1 | 2012 | 213 | 0.090 |
Why?
| | Obesity | 2 | 2017 | 2530 | 0.090 |
Why?
| | Carotenoids | 3 | 2001 | 34 | 0.090 |
Why?
| | Cooking | 1 | 2011 | 53 | 0.090 |
Why?
| | Xerophthalmia | 2 | 2004 | 7 | 0.090 |
Why?
| | Drug Therapy | 1 | 1990 | 78 | 0.090 |
Why?
| | Northwestern United States | 1 | 2008 | 54 | 0.080 |
Why?
| | Southwestern United States | 1 | 2008 | 92 | 0.080 |
Why?
| | Feasibility Studies | 2 | 2023 | 750 | 0.080 |
Why?
| | Education, Continuing | 1 | 2008 | 40 | 0.080 |
Why?
| | Electrodes, Implanted | 2 | 1978 | 93 | 0.080 |
Why?
| | Premedication | 1 | 1987 | 36 | 0.070 |
Why?
| | Pain | 1 | 2012 | 713 | 0.070 |
Why?
| | Vitamin E | 1 | 1987 | 111 | 0.070 |
Why?
| | Patient Education as Topic | 1 | 1991 | 686 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 1724 | 0.070 |
Why?
| | Retinol-Binding Proteins | 1 | 2005 | 13 | 0.070 |
Why?
| | Exercise | 2 | 2008 | 1611 | 0.060 |
Why?
| | Animals | 13 | 2017 | 32123 | 0.060 |
Why?
| | Pregnancy Trimester, Third | 1 | 2005 | 77 | 0.060 |
Why?
| | Feces | 4 | 2012 | 374 | 0.060 |
Why?
| | Electric Conductivity | 3 | 1979 | 91 | 0.060 |
Why?
| | Cardiac Catheterization | 2 | 1978 | 535 | 0.060 |
Why?
| | Health Promotion | 1 | 2011 | 690 | 0.060 |
Why?
| | Wound Healing | 1 | 1987 | 263 | 0.060 |
Why?
| | Cryosurgery | 2 | 1995 | 51 | 0.060 |
Why?
| | Vitamin D Deficiency | 1 | 2005 | 159 | 0.060 |
Why?
| | Urban Population | 2 | 2004 | 407 | 0.060 |
Why?
| | Panama | 4 | 1992 | 9 | 0.060 |
Why?
| | Educational Status | 2 | 2008 | 429 | 0.050 |
Why?
| | Dogs | 7 | 1980 | 344 | 0.050 |
Why?
| | Gels | 2 | 1979 | 72 | 0.050 |
Why?
| | Uganda | 1 | 2022 | 68 | 0.050 |
Why?
| | Substance-Related Disorders | 1 | 1990 | 953 | 0.050 |
Why?
| | Food Preferences | 2 | 2000 | 108 | 0.050 |
Why?
| | Zambia | 1 | 2022 | 69 | 0.050 |
Why?
| | South Africa | 1 | 2022 | 162 | 0.050 |
Why?
| | Time Factors | 6 | 2012 | 6186 | 0.050 |
Why?
| | Plant Oils | 1 | 2001 | 28 | 0.050 |
Why?
| | Aged | 3 | 2016 | 19299 | 0.050 |
Why?
| | Cardiography, Impedance | 1 | 1980 | 6 | 0.040 |
Why?
| | Plethysmography, Impedance | 1 | 1980 | 5 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2016 | 1665 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 1994 | 1444 | 0.040 |
Why?
| | Biogenic Amines | 1 | 1999 | 4 | 0.040 |
Why?
| | Lactation | 1 | 2001 | 149 | 0.040 |
Why?
| | Self Medication | 1 | 1999 | 9 | 0.040 |
Why?
| | Xanthines | 1 | 1999 | 15 | 0.040 |
Why?
| | Ghana | 1 | 2019 | 30 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2000 | 48 | 0.040 |
Why?
| | Food Analysis | 1 | 1999 | 18 | 0.040 |
Why?
| | Psychological Techniques | 1 | 1999 | 7 | 0.040 |
Why?
| | Milk, Human | 1 | 2001 | 128 | 0.040 |
Why?
| | Social Responsibility | 1 | 2019 | 45 | 0.040 |
Why?
| | Respiration | 1 | 1980 | 180 | 0.040 |
Why?
| | Thorax | 1 | 1979 | 41 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 1999 | 110 | 0.040 |
Why?
| | Schools, Medical | 1 | 2000 | 125 | 0.040 |
Why?
| | Focus Groups | 1 | 2000 | 386 | 0.040 |
Why?
| | Encephalitozoon | 1 | 1998 | 2 | 0.040 |
Why?
| | Encephalitozoonosis | 1 | 1998 | 2 | 0.040 |
Why?
| | Cholesterol | 1 | 2000 | 367 | 0.040 |
Why?
| | Bias | 1 | 1999 | 184 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 2392 | 0.040 |
Why?
| | Nicotine | 1 | 2000 | 267 | 0.040 |
Why?
| | Energy Metabolism | 2 | 2000 | 712 | 0.040 |
Why?
| | Ointments | 1 | 1977 | 23 | 0.040 |
Why?
| | Interprofessional Relations | 1 | 2020 | 258 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2004 | 3054 | 0.040 |
Why?
| | Weight Gain | 1 | 2000 | 455 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2023 | 2437 | 0.040 |
Why?
| | Education, Medical | 1 | 2000 | 224 | 0.040 |
Why?
| | Cell Membrane | 1 | 2000 | 682 | 0.030 |
Why?
| | Odds Ratio | 2 | 2000 | 969 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2012 | 1817 | 0.030 |
Why?
| | Placebos | 1 | 2016 | 198 | 0.030 |
Why?
| | Visual Acuity | 2 | 1995 | 273 | 0.030 |
Why?
| | Hookworm Infections | 2 | 2012 | 3 | 0.030 |
Why?
| | Colonic Neoplasms | 1 | 1997 | 221 | 0.030 |
Why?
| | Diarrhea, Infantile | 1 | 1994 | 8 | 0.030 |
Why?
| | Smoking Prevention | 1 | 2016 | 156 | 0.030 |
Why?
| | Cryptosporidiosis | 1 | 1994 | 13 | 0.030 |
Why?
| | Cryptosporidium parvum | 1 | 1994 | 13 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2019 | 475 | 0.030 |
Why?
| | Laser Therapy | 1 | 1995 | 99 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1993 | 170 | 0.030 |
Why?
| | Diarrhea | 1 | 1994 | 173 | 0.030 |
Why?
| | China | 1 | 1993 | 168 | 0.030 |
Why?
| | Oregon | 1 | 2012 | 66 | 0.030 |
Why?
| | Body Height | 1 | 1993 | 185 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 990 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2000 | 1728 | 0.030 |
Why?
| | Body Weights and Measures | 1 | 2012 | 32 | 0.030 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2012 | 9 | 0.030 |
Why?
| | Cultural Characteristics | 1 | 1992 | 58 | 0.030 |
Why?
| | Overweight | 1 | 2016 | 468 | 0.020 |
Why?
| | Ferrous Compounds | 1 | 1991 | 22 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 1868 | 0.020 |
Why?
| | Florida | 1 | 1991 | 73 | 0.020 |
Why?
| | Micronesia | 1 | 2011 | 3 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2012 | 437 | 0.020 |
Why?
| | Parity | 1 | 1991 | 99 | 0.020 |
Why?
| | Ventricular Fibrillation | 3 | 1980 | 50 | 0.020 |
Why?
| | Nutritional Requirements | 1 | 2011 | 71 | 0.020 |
Why?
| | Body Weight | 2 | 1993 | 872 | 0.020 |
Why?
| | Pain Measurement | 1 | 2012 | 450 | 0.020 |
Why?
| | Health Surveys | 1 | 2012 | 449 | 0.020 |
Why?
| | Vitamins | 1 | 1991 | 151 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2012 | 353 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1226 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2012 | 9166 | 0.020 |
Why?
| | Risk Reduction Behavior | 1 | 2011 | 196 | 0.020 |
Why?
| | Pediatric Obesity | 1 | 2016 | 492 | 0.020 |
Why?
| | Residence Characteristics | 1 | 1991 | 277 | 0.020 |
Why?
| | Mass Screening | 2 | 1997 | 1023 | 0.020 |
Why?
| | Drug Interactions | 1 | 1990 | 347 | 0.020 |
Why?
| | Public Assistance | 1 | 1988 | 18 | 0.020 |
Why?
| | Health Services Research | 1 | 1991 | 376 | 0.020 |
Why?
| | Smoking | 1 | 2016 | 1468 | 0.020 |
Why?
| | Lactose | 1 | 1987 | 6 | 0.020 |
Why?
| | Gastrointestinal Transit | 1 | 1987 | 6 | 0.020 |
Why?
| | Digestion | 1 | 1987 | 9 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 396 | 0.020 |
Why?
| | Hematocrit | 1 | 1987 | 86 | 0.020 |
Why?
| | Breath Tests | 1 | 1987 | 85 | 0.020 |
Why?
| | Hydrogen | 1 | 1987 | 62 | 0.020 |
Why?
| | Diet, Reducing | 1 | 2008 | 79 | 0.020 |
Why?
| | Hydroxyproline | 1 | 1987 | 22 | 0.020 |
Why?
| | Health Status | 1 | 2012 | 733 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1987 | 376 | 0.020 |
Why?
| | Developing Countries | 1 | 1988 | 242 | 0.020 |
Why?
| | Mexico | 2 | 1998 | 164 | 0.020 |
Why?
| | Personality Assessment | 1 | 2006 | 79 | 0.020 |
Why?
| | Hemoglobins | 1 | 1987 | 313 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 2 | 1998 | 399 | 0.020 |
Why?
| | Calcium | 1 | 1991 | 1102 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2598 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 1994 | 4446 | 0.020 |
Why?
| | Mental Recall | 1 | 2006 | 173 | 0.020 |
Why?
| | Collagen | 1 | 1987 | 415 | 0.010 |
Why?
| | Surgical Procedures, Operative | 1 | 1987 | 210 | 0.010 |
Why?
| | Social Support | 1 | 2008 | 541 | 0.010 |
Why?
| | Blood Proteins | 1 | 2005 | 238 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 961 | 0.010 |
Why?
| | Sex Factors | 2 | 2000 | 1741 | 0.010 |
Why?
| | Palm Oil | 1 | 2001 | 2 | 0.010 |
Why?
| | Honduras | 1 | 2001 | 5 | 0.010 |
Why?
| | beta Carotene | 1 | 2001 | 18 | 0.010 |
Why?
| | Lutein | 1 | 2001 | 12 | 0.010 |
Why?
| | Administration, Cutaneous | 1 | 2000 | 116 | 0.010 |
Why?
| | Energy Transfer | 1 | 1980 | 47 | 0.010 |
Why?
| | Skin Physiological Phenomena | 1 | 1979 | 26 | 0.010 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2000 | 106 | 0.010 |
Why?
| | Electronics, Medical | 1 | 1978 | 8 | 0.010 |
Why?
| | Research Support as Topic | 1 | 2000 | 108 | 0.010 |
Why?
| | Retrospective Studies | 2 | 1995 | 12616 | 0.010 |
Why?
| | Rats | 1 | 1987 | 5035 | 0.010 |
Why?
| | Social Behavior | 1 | 2000 | 267 | 0.010 |
Why?
| | Surface Properties | 1 | 1979 | 397 | 0.010 |
Why?
| | Water Supply | 1 | 1998 | 71 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1977 | 79 | 0.010 |
Why?
| | Dietary Supplements | 1 | 2001 | 460 | 0.010 |
Why?
| | Antioxidants | 1 | 2001 | 533 | 0.010 |
Why?
| | Dietary Fiber | 1 | 1997 | 40 | 0.010 |
Why?
| | Calcium, Dietary | 1 | 1997 | 55 | 0.010 |
Why?
| | Eligibility Determination | 1 | 1997 | 61 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 1980 | 301 | 0.010 |
Why?
| | Heart Arrest | 1 | 1980 | 289 | 0.010 |
Why?
| | Colonic Polyps | 1 | 1997 | 67 | 0.010 |
Why?
| | Coronary Disease | 1 | 1978 | 349 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 1977 | 275 | 0.010 |
Why?
| | Risk | 1 | 1997 | 830 | 0.010 |
Why?
| | Statistics as Topic | 1 | 1995 | 299 | 0.010 |
Why?
| | Treatment Failure | 1 | 1995 | 333 | 0.010 |
Why?
| | Patient Selection | 1 | 1997 | 656 | 0.010 |
Why?
| | Reoperation | 1 | 1995 | 526 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 1997 | 862 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 1998 | 1262 | 0.010 |
Why?
| | Models, Biological | 1 | 1977 | 1647 | 0.010 |
Why?
| | New York City | 1 | 1988 | 74 | 0.000 |
Why?
| | New York | 1 | 1988 | 110 | 0.000 |
Why?
| | Entamoebiasis | 1 | 1988 | 1 | 0.000 |
Why?
| | Giardiasis | 1 | 1988 | 14 | 0.000 |
Why?
| | Incidence | 1 | 1994 | 2333 | 0.000 |
Why?
| | Trichuriasis | 1 | 1988 | 4 | 0.000 |
Why?
| | Parasite Egg Count | 1 | 1987 | 5 | 0.000 |
Why?
| | Ascaris | 1 | 1987 | 2 | 0.000 |
Why?
| | Cohort Studies | 1 | 1997 | 4960 | 0.000 |
Why?
| | Electrocardiography | 2 | 1980 | 554 | 0.000 |
Why?
| | Seasons | 1 | 1988 | 458 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1997 | 6438 | 0.000 |
Why?
| | United States | 1 | 2000 | 12338 | 0.000 |
Why?
| | Heart Massage | 1 | 1980 | 7 | 0.000 |
Why?
| | Heart Block | 1 | 1980 | 37 | 0.000 |
Why?
| | Necrosis | 1 | 1980 | 211 | 0.000 |
Why?
| | Epinephrine | 1 | 1980 | 166 | 0.000 |
Why?
| | Resuscitation | 1 | 1980 | 248 | 0.000 |
Why?
| | Respiration, Artificial | 1 | 1980 | 525 | 0.000 |
Why?
| | Myocardium | 1 | 1980 | 929 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1980 | 3582 | 0.000 |
Why?
|
|
Taren's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|